ArticleNature cancer2026

Spatiotemporal control of SMARCA5 by a MAPK-RUNX1 axis distinguishes mutant KRAS-driven pancreatic malignancy from tissue regeneration.

Jing Han et al.PubMed ↗Publisher ↗

No numbers read from the abstract.